The University of New Mexico Hospital is a public teaching hospital located in Albuquerque, New Mexico, immediately north of the main campus of the University of New Mexico.

There are 556 beds in University of New Mexico Hospital.

During the past decade, University of New Mexico Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 9 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 5 clinical trials were completed. i.e. 29.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of New Mexico Hospital" #1 sponsor was "University of New Mexico" with 18 trials, followed by "Celgene" with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Sanofi" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of New Mexico Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 3 trials as a collaborator, "University of Pittsburgh" with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "University of New Mexico Hospital" are "Crohn Disease" (3 trials), "Acute Ischemic Stroke" (2 trials), "Atrial Fibrillation" (2 trials), "COVID-19" (2 trials) and "Cervical Ripening" (2 trials). Many other conditions were trialed in "University of New Mexico Hospital" in a lesser frequency.

Most popular intervention types in "University of New Mexico Hospital" are "Drug" (25 trials), "Behavioral" (6 trials), "Device" (6 trials), "Other" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ozanimod" (3 trials), "Dexamethasone" (2 trials), "SR34006 (idraparinux sodium) Injection" (2 trials) and "0.9% Normal Saline (0.9% Sodium Chloride) injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of New Mexico Hospital" are 41 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "University of New Mexico Hospital". undefined are not yet recruiting, 12 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in University of New Mexico Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of New Mexico Hospital, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".